Universe Pharmaceuticals (UPC) Inventory (2020 - 2025)

Universe Pharmaceuticals has disclosed Inventory across 6 years of filings, most recently posting $2.5 billion for Q3 2025.

• Inventory for Q3 2025 came in at $2.5 billion, up 43.33% year-over-year; the trailing twelve-month figure through Sep 2025 was $2.5 billion (up 43.33% YoY), and the FY2025 annual result was $2.5 billion, up 43.33% from the prior year.
• Inventory came in at $2.5 billion for Q3 2025 at Universe Pharmaceuticals, up from $1.7 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $2.5 billion in Q3 2025 to a low of -$488746.0 in Q1 2023.
• The 5-year median for Inventory is $1.3 million (2021), against an average of $529.0 million.
• Across the five-year window, Inventory sank 114.43% in 2023 and soared 961494.97% in 2024, its largest moves.
• Universe Pharmaceuticals' Inventory stood at $2.5 million in 2021, then plunged by 99.32% to $16701.0 in 2022, then surged by 981.63% to $180643.0 in 2023, then jumped by 961494.97% to $1.7 billion in 2024, then jumped by 43.33% to $2.5 billion in 2025.
• The last three Inventory figures came in at $2.5 billion (Q3 2025), $1.7 billion (Q3 2024), and $26553.0 (Q1 2024), per Business Quant data.